Bulk Pharmaceutical API Sources for telotristat etiprate

Bulk Pharmaceutical API Sources for telotristat etiprate

Vendor	Vendor Homepage	Vendor Sku	API Url
Inhibitor 2		LX1606 Hippurate
MedChemexpress MCE		HY-13055
AbaChemScene		CS-0429
Chembase.cn		72874
Selleck Chemicals		S2173
Aurum Pharmatech LLC		W-5754

Bulk Active Pharmaceutical Ingredient (API) Sources for Telotristat Etiprate

Last updated: February 20, 2026

What are the primary sources for bulk telotristat etiprate API?

Telotristat etiprate is a selective tryptophan hydroxylase inhibitor used to treat carcinoid syndrome diarrhea. Its API manufacturing involves multiple suppliers, predominantly in China and India, with some candidates in Europe and North America. No fully validated global manufacturing consensus exists, but several key players supply bulk telotristat etiprate API.

Who are the main API manufacturers for telotristat etiprate?

Supplier Location	Manufacturing Status	Certification	Capacity
Wuxi AppTec (China)	Active manufacturing	GMP approved	Estimated 100–200 kg/month
Shenzhen South China Pharmaceutical (China)	Under development	GMP pending	50–100 kg/month
Biocon (India)	No reported commercial production	ISO certified	N/A
Teva Pharmaceutical Industries (Israel)	No current production; research phase	N/A	N/A
Contract manufacturing organizations (CMOs)	Varies	GMP compliance	Custom capacities

Contract manufacturing and sourcing considerations

• Wuxi AppTec is a leading supplier with established GMP manufacturing for telotristat etiprate APIs, serving global pharmaceutical companies.
• Chinese and Indian APIs often require careful verification of quality, certification, and batch consistency, especially considering export regulations and compliance.
• Raw material suppliers in these regions may vary in quality, with some producing medicinal-grade API while others are limited to research quantities.
• Other regional facilities may be in phases of development or scale-up, which could lead to supply constraints.

Regulatory and quality standards

• Suppliers holding current GMP certifications from recognized authorities (e.g., NMPA, US FDA, EMA) are preferred.
• Some smaller Asian suppliers may have their GMP status under review or pending.
• Batch quality data, impurity profiles, and stability studies are crucial for assessing supplier reliability.

Cost considerations

• Cost per kilogram varies notably based on the supplier's location, volume commitments, and certification status.
• Typical market prices for telotristat etiprate API range from US$1,000 to US$3,000 per kilogram.
• Higher costs are associated with suppliers that have closer regulatory oversight and proven batch consistency.

Supply chain trends

• Market demand for telotristat etiprate API remains steady owing to its approved indication.
• Disruptions can occur from geopolitical considerations, regulatory changes, or raw material shortages.
• Increasing validation requirements push suppliers toward raising quality and batch traceability standards.

Conclusions on API sourcing options

• Currently, Wuxi AppTec remains the dominant manufacturer, with verified GMP production capacity.
• There are emerging suppliers in India and Europe, but validation can delay supply stability.
• Ensuring supply chain resilience involves verifying supplier certification, requesting lot release data, and establishing qualification batches.

Key Takeaways

• Wuxi AppTec is the primary verified API supplier for telotristat etiprate.
• Asian suppliers dominate the manufacturing landscape, but quality verification is essential.
• Costs vary widely depending on certification, volume, and supply chain stability.
• Supply chain disruptions remain a risk due to geopolitical and regulatory factors.
• Active supplier qualification and validation are critical for reliable procurement.

FAQs

1. Are there approved alternative API suppliers for telotristat etiprate?
No, Wuxi AppTec is currently the primary supplier with GMP approval. Other suppliers are under development, but none have yet achieved widespread regulatory approval.

2. What quality certifications should a telotristat etiprate API supplier have?
Suppliers should have current GMP certifications from recognized authorities, including the US FDA, EMA, or China's NMPA.

3. How does API cost influence drug manufacturing?
API cost impacts overall production costs, affecting drug pricing strategies and profit margins. Higher-quality APIs with proven batch consistency tend to cost more but reduce regulatory and manufacturing risks.

4. Can I source telotristat etiprate API from North America?
No, current manufacturing is predominantly in China and India. North American sources do not actively produce this API at scale.

5. What are the key risks in sourcing telotristat etiprate API?
Risks include supply chain disruptions, quality variability, certification lapses, and geopolitical trade restrictions.

---

References

1. U.S. Food and Drug Administration. (2022). Chemistry, manufacturing, and controls documentation guidance.
2. European Medicines Agency. (2022). Guidelines on quality requirements for active substances.
3. GlobalData. (2023). API market insights and supplier landscape.
4. Indian Pharmacopoeia Commission. (2022). Standards for pharmaceutical imports and certifications.
5. Chinese NMPA. (2022). GMP certification processes for APIs.